| Dr Zachary John Steiner, DO | |
|
4001 Laurel St, Ste 204, Anchorage, AK 99508-5300 | |
| (907) 562-8346 | |
| (907) 562-8347 |
| Full Name | Dr Zachary John Steiner |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 20 Years |
| Location | 4001 Laurel St, Anchorage, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801043013 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | 2008003314 (Missouri) | Secondary |
| 208600000X | Surgery | 46118 (Colorado) | Secondary |
| 208600000X | Surgery | 7534 (Alaska) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Alaska Medical Center | Anchorage, AK | Hospital |
| Alaska Regional Hospital | Anchorage, AK | Hospital |
| Mat-su Regional Medical Center | Palmer, AK | Hospital |
| Alaska Native Medical Center | Anchorage, AK | Hospital |
| Central Peninsula General Hospital | Soldotna, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Alyeska Trauma And Acute General Surgery Llc | 9032573712 | 8 |
| Alyeska Vascular Surgery, Llc | 2567610181 | 11 |
| Alaska Native Tribal Health Consortium | 6709780265 | 457 |
News Archive
An article published in Experimental Biology and Medicine (Volume 242, Issue 14, August 2017) reports that a plant virus-based system can be used to deliver anti-cancer drugs.
Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases today announced that Bayer Schering Pharma AG has exercised its option under the option, collaboration and license agreement entered into on January 12, 2009 to develop a new BiTE antibody for the treatment of solid tumors.
A new analysis of a landmark weight loss survey suggests that Hispanics and African Americans are more likely than whites to use unproven dietary supplements for weight loss.
Medworxx Solutions Inc. announced today it has filed with the Canadian securities authorities its interim consolidated financial statements and management discussion & analysis report for the three and nine month periods ended September 30, 2009. These documents may be viewed under the Company's profile at www.sedar.com.
› Verified 7 days ago
| Entity Name | Alyeska Vascular Surgery, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437407277 PECOS PAC ID: 2567610181 Enrollment ID: O20120924000334 |
News Archive
An article published in Experimental Biology and Medicine (Volume 242, Issue 14, August 2017) reports that a plant virus-based system can be used to deliver anti-cancer drugs.
Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases today announced that Bayer Schering Pharma AG has exercised its option under the option, collaboration and license agreement entered into on January 12, 2009 to develop a new BiTE antibody for the treatment of solid tumors.
A new analysis of a landmark weight loss survey suggests that Hispanics and African Americans are more likely than whites to use unproven dietary supplements for weight loss.
Medworxx Solutions Inc. announced today it has filed with the Canadian securities authorities its interim consolidated financial statements and management discussion & analysis report for the three and nine month periods ended September 30, 2009. These documents may be viewed under the Company's profile at www.sedar.com.
› Verified 7 days ago
| Entity Name | Alyeska Trauma & Acute General Surgery Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104517192 PECOS PAC ID: 9032573712 Enrollment ID: O20230913003689 |
News Archive
An article published in Experimental Biology and Medicine (Volume 242, Issue 14, August 2017) reports that a plant virus-based system can be used to deliver anti-cancer drugs.
Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases today announced that Bayer Schering Pharma AG has exercised its option under the option, collaboration and license agreement entered into on January 12, 2009 to develop a new BiTE antibody for the treatment of solid tumors.
A new analysis of a landmark weight loss survey suggests that Hispanics and African Americans are more likely than whites to use unproven dietary supplements for weight loss.
Medworxx Solutions Inc. announced today it has filed with the Canadian securities authorities its interim consolidated financial statements and management discussion & analysis report for the three and nine month periods ended September 30, 2009. These documents may be viewed under the Company's profile at www.sedar.com.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zachary John Steiner, DO 4001 Laurel St, Ste 204, Anchorage, AK 99508-5300 Ph: (907) 562-8346 | Dr Zachary John Steiner, DO 4001 Laurel St, Ste 204, Anchorage, AK 99508-5300 Ph: (907) 562-8346 |
News Archive
An article published in Experimental Biology and Medicine (Volume 242, Issue 14, August 2017) reports that a plant virus-based system can be used to deliver anti-cancer drugs.
Micromet, Inc., a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases today announced that Bayer Schering Pharma AG has exercised its option under the option, collaboration and license agreement entered into on January 12, 2009 to develop a new BiTE antibody for the treatment of solid tumors.
A new analysis of a landmark weight loss survey suggests that Hispanics and African Americans are more likely than whites to use unproven dietary supplements for weight loss.
Medworxx Solutions Inc. announced today it has filed with the Canadian securities authorities its interim consolidated financial statements and management discussion & analysis report for the three and nine month periods ended September 30, 2009. These documents may be viewed under the Company's profile at www.sedar.com.
› Verified 7 days ago
Dr. Bijiibaa' K Garrison, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 520-390-8275 | |
Dr. Jeffrey Charles Congdon, MD Surgery Medicare: Medicare Enrolled Practice Location: 2925 Debarr Rd, Anchorage, AK 99508 Phone: 907-257-4869 | |
Kevin Joseph Stange, MD Surgery Medicare: Medicare Enrolled Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662 | |
Dr. Regina Sutton Chennault, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 2751 Debarr Rd, Suite 280a, Anchorage, AK 99508 Phone: 907-222-6888 Fax: 907-222-6884 | |
Mark James Thorndike, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 4315 Diplomacy Dr, Anchorage, AK 99508 Phone: 907-563-2662 | |
Dr. Priya Patel, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 4001 Laurel St Ste 204, Anchorage, AK 99508 Phone: 907-562-8346 | |
Dr. Madhu Prasad, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 2925 Debarr Rd Ste D350, Anchorage, AK 99508 Phone: 907-276-3676 Fax: 907-276-3679 |